Close Menu

Scott Gottlieb, the former commissioner of the US Food and Drug Administration who resigned as head of the agency in April, has gone back to his old job: he has been rehired at the venture capital firm New Enterprise Associates (NEA) as a special partner on its healthcare investment team, according to MedCity News. Gottlieb had previously served as venture partner at NEA from 2007 until 2017, when he was appointed as FDA commissioner.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.